Showing results (2811-2820 of 31,410) with videos related to
Sort By:
Pageof 3,141
Journal of Medicinal Chemistry|February 23, 2010
1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitorsFabrizio Micheli, Paolo Cavanni, Roberto Arban, et al.Journal of Medicinal Chemistry|December 1, 1977
1,2,4-Triazole amino nucleosides. 1-beta-D-3'-Amino-3'-deoxyribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosidesA S Narang, R VinceJournal of Medicinal Chemistry|February 25, 2010
Discovery and SAR of thiazolidine-2,4-dione analogues as insulin-like growth factor-1 receptor (IGF-1R) inhibitors via hierarchical virtual screeningXiaofeng Liu, Hua Xie, Cheng Luo, et al.Journal of Medicinal Chemistry|February 26, 2010
Dopamine receptor ligands. Part 18: (1) modification of the structural skeleton of indolobenzazecine-type dopamine receptor antagonistsDina Robaa, Christoph Enzensperger, Shams El Din Abul Azm, et al.Journal of Medicinal Chemistry|September 9, 2016
Versatile Picklocks To Access All Opioid Receptors: Tuning the Selectivity and Functional Profile of the Cyclotetrapeptide c[Phe-d-Pro-Phe-Trp] (CJ-15,208)Rossella De Marco, Andrea Bedini, Santi Spampinato, et al.Journal of Medicinal Chemistry|September 9, 2016
The Oncolytic Efficacy and in Vivo Pharmacokinetics of [2-(4-Chlorophenyl)quinolin-4-yl](piperidine-2-yl)methanol (Vacquinol-1) Are Governed by Distinct Stereochemical FeaturesLars G J Hammarström, Robert K Harmel, Mikael Granath, et al.Journal of Medicinal Chemistry|September 13, 2016
A Novel Parkinson's Disease Drug Candidate with Potent Anti-neuroinflammatory Effects through the Src Signaling PathwayYa-Dan Wang, Xiu-Qi Bao, Song Xu, et al.Journal of Medicinal Chemistry|September 8, 2016
Amending HIV Drugs: A Novel Small-Molecule Approach To Target Lupus Anti-DNA AntibodiesSonya VanPatten, Shan Sun, Mingzhu He, et al.Journal of Medicinal Chemistry|September 9, 2016
Discovery of an Orally Bioavailable Gonadotropin-Releasing Hormone Receptor AntagonistSeon-Mi Kim, Minhee Lee, So Young Lee, et al.Journal of Medicinal Chemistry|September 9, 2016
Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer's DiseaseObdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.Pageof 3,141